Clinical Trials Browser

Phase 2 × envafolimab × Tumor-Agnostic × Clear all

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Phase 2 Unknown

Neoplasm Metastasis